Page last updated: 2024-09-05

lu 135252 and Body Weight

lu 135252 has been researched along with Body Weight in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (22.22)18.2507
2000's7 (77.78)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dieterich, M; Kossmehl, P; Kreutz, R; Rothermund, L; Traupe, T; Yagil, C; Yagil, Y1
Amann, K; El-Shakmak, A; Gross, ML; Hansen, A; Heiss, N; Münter, K; Ritz, E; Szabo, A; Weckbach, M1
Nathan, T; Rose, T; Simoni, J; Tran, RM; Wesson, DE1
Amann, K; Banas, B; Orth, SR; Ritz, E; Schiele, G1
Amann, K; Esslinger, JP; Orth, SR; Raschack, M; Ritz, E; Schwarz, U1
Barton, M; d'Uscio, LV; Lüscher, TF; Moreau, P; Shaw, S1
Aus Dem Spring, C; Bollig, K; Dhein, S; Hochreuther, S; Hufnagel, C; Raschack, M1
deGottardi, A; Enseleit, F; Hürlimann, D; Lüscher, TF; Noll, G; Quaschning, T; Rossier, MF; Ruschitzka, F; Shaw, SG1
Aadahl, P; Arbo, I; Ellingsen, O; Loennechen, JP; Nilsen, OG; Nilsen, T; Sandvik, AK; Waldum, HL1

Other Studies

9 other study(ies) available for lu 135252 and Body Weight

ArticleYear
Nephroprotective effects of the endothelin ET(A) receptor antagonist darusentan in salt-sensitive genetic hypertension.
    European journal of pharmacology, 2003, May-16, Volume: 468, Issue:3

    Topics: Albuminuria; Animals; Body Weight; Desoxycorticosterone; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin-1; Hypertension; Kidney; Kidney Diseases; Male; Organ Size; Osteopontin; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred Strains; Receptor, Endothelin A; Receptor, Endothelin B; RNA, Messenger; Sialoglycoproteins; Sodium; Sodium Chloride, Dietary

2003
ACE-inhibition is superior to endothelin A receptor blockade in preventing abnormal capillary supply and fibrosis of the heart in experimental diabetes.
    Diabetologia, 2004, Volume: 47, Issue:2

    Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Arterioles; Blood Glucose; Blood Pressure; Body Weight; Cardiovascular Diseases; Collagen Type IV; Coronary Vessels; Diabetes Mellitus, Experimental; Endothelin A Receptor Antagonists; Endothelin-1; Fibrosis; Gene Expression; Heart; Immunohistochemistry; In Situ Hybridization; Indoles; Male; Myocardium; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Transforming Growth Factor beta

2004
Dietary protein induces endothelin-mediated kidney injury through enhanced intrinsic acid production.
    Kidney international, 2007, Volume: 71, Issue:3

    Topics: Acidosis, Renal Tubular; Acids; Animals; Bicarbonates; Body Weight; Bosentan; Caseins; Dietary Proteins; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Male; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred Strains; Receptor, Endothelin A; Receptor, Endothelin B; Sulfonamides

2007
Effect of a selective endothelin receptor A blocker on cardiovascular remodeling in uninephrectomized spontaneously hypertensive rats of the stroke-prone strain.
    Kidney & blood pressure research, 2007, Volume: 30, Issue:6

    Topics: Animals; Aorta, Thoracic; Arterioles; Blood Pressure; Body Weight; Cardiovascular System; Disease Models, Animal; Endothelin A Receptor Antagonists; Genetic Predisposition to Disease; Hypertrophy; Male; Nephrectomy; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred SHR; Stroke; Tunica Media; Ventricular Remodeling

2007
Nephroprotection of an ET(A)-receptor blocker (LU 135252) in salt-loaded uninephrectomized stroke-prone spontaneously hypertensive rats.
    Hypertension (Dallas, Tex. : 1979), 1998, Volume: 31, Issue:4

    Topics: Animals; Blood Pressure; Body Weight; Cerebrovascular Disorders; Endothelin Receptor Antagonists; Endothelin-1; Kidney; Male; Nephrectomy; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred SHR; Receptor, Endothelin A; Sodium, Dietary

1998
Differential modulation of the renal and myocardial endothelin system by angiotensin II in Vivo. Effects of chronic selective ETA receptor blockade.
    Journal of cardiovascular pharmacology, 1998, Volume: 31 Suppl 1

    Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Endothelin Receptor Antagonists; Endothelin-1; Heart; Kidney; Male; Myocardium; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred WKY; Receptor, Endothelin A

1998
Long-term effects of the endothelin(A) receptor antagonist LU 135252 and the angiotensin-converting enzyme inhibitor trandolapril on diabetic angiopathy and nephropathy in a chronic type I diabetes mellitus rat model.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 293, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Blood Vessels; Body Weight; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diabetic Nephropathies; Endothelin Receptor Antagonists; Endothelium, Vascular; Erythrocytes; Heart Rate; Indoles; Kidney Function Tests; Male; Muscle, Smooth, Vascular; Myocardium; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A

2000
Endothelin 1 type a receptor antagonism prevents vascular dysfunction and hypertension induced by 11beta-hydroxysteroid dehydrogenase inhibition: role of nitric oxide.
    Circulation, 2001, Jun-26, Volume: 103, Issue:25

    Topics: 11-beta-Hydroxysteroid Dehydrogenases; Acetylcholine; Animals; Blood Pressure; Body Weight; Cells, Cultured; Corticosterone; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Endothelium, Vascular; Gene Expression Regulation; Glycyrrhizic Acid; Heart Rate; Humans; Hydroxysteroid Dehydrogenases; Hypertension; Male; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Norepinephrine; Phenylpropionates; Potassium Chloride; Protein Precursors; Pyrimidines; Rats; Rats, Inbred WKY; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; RNA, Messenger; Vascular Diseases; Vasoconstriction; Vasodilation; Vasodilator Agents; Verapamil

2001
Chronic exposure to carbon monoxide and nicotine: endothelin ET(A) receptor antagonism attenuates carbon monoxide-induced myocardial hypertrophy in rat.
    Toxicology and applied pharmacology, 2002, Jan-01, Volume: 178, Issue:1

    Topics: Animals; Atmosphere Exposure Chambers; Atrial Natriuretic Factor; Body Weight; Carbon Monoxide; Cardiomegaly; Endothelin Receptor Antagonists; Endothelin-1; Female; Nicotine; Nicotinic Agonists; Organ Size; Phenylpropionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; RNA, Messenger

2002